Ebola vaccine trials are a top priority for medical authorities

Citing the U.S. Defense Threat Reduction Agency (DTRA) desire to "move quickly" on validating an Ebola vaccine, NewLink Genetics (NLNK +11.8%) says it has enough doses of its vaccine candidate to launch a safety trial in 20 -100 healthy volunteers in a matter of weeks. CEO Dr. Charles Link says he has lined up two (possibly three) contract manufacturers that could produce tens of thousands of doses within a month or two.

NewLink subsidiary BioProtection Systems received $1M from DTRA to fund more pre-clinical toxicology studies and stepped-up manufacturing to allow human trials to start quickly.

Tekmira Pharmaceuticals (TKMR -9.2%) began a Phase 1 trial of TKM-Ebola in January of this year. It is the only product candidate to be tested on humans to date.

GlaxoSmithKline (GSK +0.7%) awaits FDA approval to commence a safety trial for its Ebola vaccine candidate. The trial could start as early as September.

Mapp Biopharmaceutical's ZMapp Ebola vaccine was given to the two American medical workers who contracted the disease. Its supply is now exhausted.

From other sites
Comments (7)
  • Trick Play
    , contributor
    Comments (11) | Send Message
    TKM-Ebola is not a vaccine, it's a therapeutic----big difference!
    14 Aug 2014, 01:24 PM Reply Like
  • Haz_math
    , contributor
    Comments (6) | Send Message
    How long till $NVAX's name gets tossed around?
    14 Aug 2014, 01:28 PM Reply Like
  • Tricia D
    , contributor
    Comments (20) | Send Message
    NLNK CEO is shamless hawker.
    The Vaccine Companies are BCRX and GSK ( Nlnk got a $1M for its subsidiary ... BCRX US Gov't contract is $23 +4.1 M expansion added yesterday


    As mentioned already TKM-EBOL is NOT a vaccine ...


    Why can't Seeking Alpha CHECK FACTS ...
    14 Aug 2014, 01:29 PM Reply Like
  • awolm311
    , contributor
    Comment (1) | Send Message
    Sarepta's (NASDAQ:SRPT) effective ebola treatment has been successfully tested on humans
    14 Aug 2014, 01:38 PM Reply Like
  • Dong712
    , contributor
    Comments (28) | Send Message
    Good article, glad to see that NLNK is getting the recognition for providing the needed serum to help those victims through Canadian authorities.....This drug has shown 100% efficacy in Primates, even those already infected....All other products are "Smoke and Mirrors".....
    14 Aug 2014, 05:10 PM Reply Like
  • Trick Play
    , contributor
    Comments (11) | Send Message
    You read it here first: vials containing TKM-Ebola will be shipped off to Africa for use in infected individuals; it is only a matter of time and in my opinion will be before Friday next week; also, the timeframe to build enough inventory to treat all of those fighting the virus will be reduced to several weeks; and once that is achieved, the supply of the drug will be able to keep up with new cases.
    15 Aug 2014, 09:10 AM Reply Like
  • Tricia D
    , contributor
    Comments (20) | Send Message
    Vaccine Candidates are GSK, BCRX


    TKM will initiate a 15 pt controlled trial
    1 Sep 2014, 08:30 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs